220 related articles for article (PubMed ID: 15681799)
1. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
[TBL] [Abstract][Full Text] [Related]
2. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
[TBL] [Abstract][Full Text] [Related]
3. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.
Rogers JT; Randall JD; Cahill CM; Eder PS; Huang X; Gunshin H; Leiter L; McPhee J; Sarang SS; Utsuki T; Greig NH; Lahiri DK; Tanzi RE; Bush AI; Giordano T; Gullans SR
J Biol Chem; 2002 Nov; 277(47):45518-28. PubMed ID: 12198135
[TBL] [Abstract][Full Text] [Related]
4. Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.
Bandyopadhyay S; Huang X; Cho H; Greig NH; Youdim MB; Rogers JT
J Neural Transm Suppl; 2006; (71):237-47. PubMed ID: 17447434
[TBL] [Abstract][Full Text] [Related]
5. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
[TBL] [Abstract][Full Text] [Related]
6. FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.
Morse LJ; Payton SM; Cuny GD; Rogers JT
J Mol Neurosci; 2004; 24(1):129-36. PubMed ID: 15314261
[TBL] [Abstract][Full Text] [Related]
7. Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.
Bandyopadhyay S; Cahill C; Balleidier A; Huang C; Lahiri DK; Huang X; Rogers JT
PLoS One; 2013; 8(7):e65978. PubMed ID: 23935819
[TBL] [Abstract][Full Text] [Related]
8. A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.
Bandyopadhyay S; Ni J; Ruggiero A; Walshe K; Rogers MS; Chattopadhyay N; Glicksman MA; Rogers JT
J Biomol Screen; 2006 Aug; 11(5):469-80. PubMed ID: 16928984
[TBL] [Abstract][Full Text] [Related]
9. Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease.
Maloney B; Ge YW; Greig N; Lahiri DK
FASEB J; 2004 Aug; 18(11):1288-90. PubMed ID: 15208260
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.
Lahiri DK; Ge YW; Maloney B
FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Iron-Response Elements of the mRNAs for the Alzheimer's Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity.
Rogers JT; Xia N; Wong A; Bakshi R; Cahill CM
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823541
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region.
Ge YW; Ghosh C; Song W; Maloney B; Lahiri DK
J Neurochem; 2004 Sep; 90(6):1432-44. PubMed ID: 15341527
[TBL] [Abstract][Full Text] [Related]
13. Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells.
Westmark PR; Shin HC; Westmark CJ; Soltaninassab SR; Reinke EK; Malter JS
Neurobiol Aging; 2006 Jun; 27(6):787-96. PubMed ID: 16672170
[TBL] [Abstract][Full Text] [Related]
14. Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.
Shaw KT; Utsuki T; Rogers J; Yu QS; Sambamurti K; Brossi A; Ge YW; Lahiri DK; Greig NH
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7605-10. PubMed ID: 11404470
[TBL] [Abstract][Full Text] [Related]
15. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
[TBL] [Abstract][Full Text] [Related]
16. A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.
Rogers JT; Venkataramani V; Washburn C; Liu Y; Tummala V; Jiang H; Smith A; Cahill CM
J Neurochem; 2016 Aug; 138(3):479-94. PubMed ID: 27206843
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery targeted to the Alzheimer's APP mRNA 5'-untranslated region: the action of paroxetine and dimercaptopropanol.
Payton S; Cahill CM; Randall JD; Gullans SR; Rogers JT
J Mol Neurosci; 2003; 20(3):267-75. PubMed ID: 14501007
[TBL] [Abstract][Full Text] [Related]
18. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells.
Zhang J; Mori A; Chen Q; Zhao B
Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide.
Utsuki T; Yu QS; Davidson D; Chen D; Holloway HW; Brossi A; Sambamurti K; Lahiri DK; Greig NH; Giordano T
J Pharmacol Exp Ther; 2006 Aug; 318(2):855-62. PubMed ID: 16690718
[TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
